A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'

International Journal of Geriatric Psychiatry

Volumn 16, Issue 3, 2001, Pages 254-260

  Taragano, Fernando E ^a   Allegri, Ricardo ^a   Vicario, Augusto ^a   Bagnatti, Pablo ^a   Lyketsos, Constantine G ^b,c  

^a CEMIC   (Argentina)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Geriatric psychiatry; Major depression cerebrovascular disease; Nimodipine; Treatment augmentation

Indexed keywords

ANTIDEPRESSANT AGENT; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; NIMODIPINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; BRONCHITIS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOBIA; POPULATION RISK; PREMATURE EJACULATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR DISORDERS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NIMODIPINE; RECURRENCE;

EID: 0035072237     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.340     Document Type: Article

References (5)

1. 'Vascular depression' hypothesis
2. Nimodipine
3. Does stroke cause depression?
4. Nortriptyline versus fluoxetine in the treatment of depression and in the short-term recovery after stroke: A placebo-controlled study